NRG produces, among others, the following isotopes:
Molybdenum which is used in imaging techniques to diagnose diseases in the areas of cardiology, oncology, neurology and urology.
Several Iodine isotopes which have a number of applications including the treatment of thyroid gland disorders and prostate cancer.
Iridium which is used as source in brachy-therapy for to the irradiation of several types of tumors, for example, those that occur in the neck and head areas and in the uterus.
Lutetium and Yttrium which are becoming promising therapies for the treatment of cancer of the stomach, pancreas and intestines. Patients’ life expectancy can be increased and they can enjoy a better quality of life.
Phosphorus which is used in numerous therapies and is proving promising in the suppression of cancer of the pancreas.
Samarium, Rhenium and Strontium which are used in the suppression pain arising from bone cancer. They prevent the further (painful) increase of bone cancer cells.
Erbium and Yttrium which are used for the suppression of pain from arthritis .
There is continuing growth in the development of diagnostic methods and therapies using radioactive isotopes. The medical sector expects and works on large breakthroughs. PALLAS has an essential contribution to make to this development.